Related Experiment Videos
Chromosome studies in myelomatosis
Virchows Archiv. B, Cell Pathology
|November 17, 1978
Summary
Cytogenetic abnormalities are common in multiple myeloma and plasma cell leukemia, affecting over half of patients. These changes, including numerical and structural aberrations, are highly variable and often involve chromosome 14.
Area of Science:
- Hematology
- Cytogenetics
- Oncology
Background:
- Multiple myeloma and plasma cell leukemia are hematologic malignancies characterized by abnormal plasma cells.
- Cytogenetic analysis is crucial for understanding the genetic landscape of these cancers.
Purpose of the Study:
- To investigate the frequency and types of chromosome abnormalities in patients with multiple myeloma and plasma cell leukemia.
- To identify common cytogenetic alterations, such as the 14q+ marker.
Main Methods:
- Cytogenetic studies were performed on bone marrow and/or PHA-stimulated peripheral blood samples.
- Chromosome banding techniques were utilized to detect numerical and structural aberrations.
Main Results:
- Chromosome abnormalities were detected in at least half of the studied patients.
- Abnormalities were highly variable, including numerical and structural aberrations.
- Hypodiploid modes were observed with notable frequency.
- A 14q+ marker (addition of material to the long arm of chromosome 14) was present in approximately 17% of patients.
Conclusions:
- Cytogenetic abnormalities are a frequent finding in multiple myeloma and plasma cell leukemia.
- The observed variability in chromosomal changes underscores the genetic heterogeneity of these diseases.
- The 14q+ marker represents a recurrent abnormality in a subset of these patients.